Risk Factors Update Summary
- Research and development expenses decreased from $31.9 million to $26.7 million.
- U.S. federal net operating loss carryforwards increased from $93.7 million to $113.7 million.
- Loss from operations decreased from $48.4 million to $40.5 million.
- Cash, equivalents, and marketable securities increased from $23.3 million to $35.0 million.
- Net loss increased from $9.7 million to $49.5 million.
- Net cash used in operating activities decreased from $39.0 million to $30.2 million.
- Accumulated deficit increased from $163.3 million to $242.7 million.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1822791&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.